Nina Langeland
Position
Professor, Professor/consultant
Affiliation
Research
Research on clinical infectious diseases and outbreak investigations. Postinfectious syndromes. Several projects on the importance of antimicrobial resistance and ESBLs on morbidity and mortality in children in Tanzania. Placebo-controlled RCTs on cotrimoxazole prophylaxis in HIV infected patients with CD4 count over 350, and on hepatitis C treatment. Recently completed RCT on probiotics to newborn babies. Clinical studies on COVID-19 including attack rate studies, vaccination and postinfectious complications. Ongoing placebo-controlled trial on antiviral treatment of COVID-19 and effect on long-term complications.
Experience in phase 1 studies, cohohort and case control studies, and randomized controlled trials.
Publications
Academic literature review
Conference lecture
Academic article
Conference abstract
Doctoral thesis (PhD)
Master鈥檚 thesis
Conference poster
Journal corrigendum
Study protocol
Letter to the editor
Media feature article
Research report